Cerebral infarction following intravenous immunoglobulin therapy for Guillain-Barre syndrome.
Intravenous immunoglobulin (IVIg) therapy is used increasingly for different immune-mediated diseases, such as the Guillain-Barre syndrome. We report the case of a 55-year-old man who developed a cerebral infarction 2 days after completion of treatment with intravenous immunoglobulin for Guillain-Barre syndrome.
Velioğlu
S K
SK
Karadeniz Technical University, Medical Faculty, Neurology Department, Trabzon, Turkey.
Ozmenoğlu
M
M
Boz
C
C